©2025 Stanford Medicine
Acute Treatment of Bipolar II Depression
Not Recruiting
Trial ID: NCT00074776
Purpose
This study will compare the medications lithium and lamotrigine (Lamictal®) in treating depression in individuals with bipolar II disorder.
Official Title
Acute Treatment of Bipolar II Depression
Stanford Investigator(s)
Eligibility
Inclusion Criteria:
* Current diagnosis of bipolar II disorder
Exclusion Criteria:
* Use of lithium or lamotrigine
* Intolerance to lithium or lamotrigine
* Substance abuse or dependence within the last month
* Suicidal thoughts
* Unstable medical conditions
* Pregnancy or breast-feeding
* Stable on current medications
* Use of fluoxetine (Prozac) within 2 weeks of study
* Require an antipsychotic medication
* Do not speak or read English
Intervention(s):
drug: Lithium
drug: Lamotrigine
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305